首页 › 基金 › Saturn V Capital Management LP › AMLX
Saturn V Capital Management LP 对 AMLX 的持仓历史
AMYLYX PHARMACEUTICALS INC · 医疗保健
Saturn V Capital Management LP 在 Q3 2026 的 13F 申报中披露持有 AMLX(AMYLYX PHARMACEUTICALS INC)4,471,356 股,市值约 US$130.1M,约占其申报组合的 19.05%,在其申报持仓中市值排名第 1 位。 Saturn V Capital Management LP 最近 13 个申报季度中有 10 个季度披露了 AMLX 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Saturn V Capital Management LP 对 AMLX 的持仓演变
Saturn V Capital Management LP 于 Q3 2023 首次披露 AMLX 持仓:886,143 股(约 US$16.2M)。 该持仓在 Q3 2026 达到峰值 4,471,356 股,市值约 US$130.1M。 在 10 次申报中,Saturn V Capital Management LP 5 次增持、3 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 4,471,356 股、市值约 US$130.1M,环比减持 -152,745 股。。 持仓曾出现大幅变动:Q1 2025 增持约 173% (随后一个季度股价上涨 81%)、Q2 2025 增持约 34% (随后一个季度股价上涨 112%)、Q3 2025 增持约 41% (随后一个季度股价下跌 11%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 886.14K | $16.23M | 新进 |
| Q4 2023 | 1.10M | $16.18M | 增持 |
| Q4 2024 | 889.07K | $3.36M | 新进 |
| Q1 2025 | 2.43M | $8.59M | 增持 |
| Q2 2025 | 3.26M | $20.90M | 增持 |
| Q3 2025 | 4.60M | $62.58M | 增持 |
| Q4 2025 | 4.50M | $54.32M | 减持 |
| Q1 2026 | 4.35M | $60.46M | 减持 |
| Q2 2026 | 4.62M | $83.05M | 增持 |
| Q3 2026 | 4.47M | $130.12M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 AMLX 与 13F 数据
AMLX(AMYLYX PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 46 只申报持有 AMLX,申报仓位最大的包括:TCG Crossover Management, LLC (US$181.7M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$158.0M), PERCEPTIVE ADVISORS LLC (US$149.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 AMLX 的基金
- TCG Crossover Management, LLC 6.24M 股 · $181.69M · Q3 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 5.43M 股 · $157.97M · Q3 2026
- PERCEPTIVE ADVISORS LLC 8.33M 股 · $149.69M · Q2 2026
- Commodore Capital LP 5.65M 股 · $101.47M · Q2 2026
- Siren, L.L.C. 2.48M 股 · $72.19M · Q3 2026
- First Light Asset Management, LLC 3.02M 股 · $54.30M · Q2 2026
- Rock Springs Capital Management LP 756.77K 股 · $22.02M · Q3 2026
- Parkman Healthcare Partners LLC 675.10K 股 · $19.65M · Q3 2026
- Almitas Capital LLC 974.88K 股 · $17.51M · Q2 2026
- Boxer Capital Management, LLC 800.00K 股 · $14.37M · Q2 2026
- GREAT POINT PARTNERS LLC 700.00K 股 · $12.57M · Q2 2026
- ADAR1 Capital Management, LLC 366.97K 股 · $10.68M · Q3 2026
更多关于 Saturn V Capital Management LP
常见问题
How long has Saturn V Capital Management LP held AMLX?
Saturn V Capital Management LP has disclosed AMLX holdings in 10 of the last 13 reported quarters, going back to Q3 2023.
What is Saturn V Capital Management LP's current position in AMLX?
As of Q3 2026, Saturn V Capital Management LP holds 4.47M shares of AMLX (AMYLYX PHARMACEUTICALS INC), valued at $130.12M, representing 19.05% of its reported portfolio and ranking #1.
Has Saturn V Capital Management LP been buying or selling AMLX?
In the latest 13F filing (Q3 2026), Saturn V Capital Management LP reduced its position in AMLX. The position peaked in Q3 2026 at 4.47M shares.
Which other funds hold AMLX?
Other major institutional holders of AMLX include TCG Crossover Management, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, PERCEPTIVE ADVISORS LLC, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.